Antiparkinsonian drugs and their neuroprotective effects.
about
MPTP mouse models of Parkinson's disease: an update.Regional expression of dopamine D1 and D2 receptor proteins in the cerebral cortex of asphyxic newborn infants.β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain.
P2860
Antiparkinsonian drugs and their neuroprotective effects.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antiparkinsonian drugs and their neuroprotective effects.
@ast
Antiparkinsonian drugs and their neuroprotective effects.
@en
Antiparkinsonian drugs and their neuroprotective effects.
@nl
type
label
Antiparkinsonian drugs and their neuroprotective effects.
@ast
Antiparkinsonian drugs and their neuroprotective effects.
@en
Antiparkinsonian drugs and their neuroprotective effects.
@nl
prefLabel
Antiparkinsonian drugs and their neuroprotective effects.
@ast
Antiparkinsonian drugs and their neuroprotective effects.
@en
Antiparkinsonian drugs and their neuroprotective effects.
@nl
P2093
P356
P1476
Antiparkinsonian drugs and their neuroprotective effects.
@en
P2093
Jun-Ichi Kakimura
Takashi Taniguchi
Yoshihisa Kitamura
P304
P356
10.1248/BPB.25.284
P577
2002-03-01T00:00:00Z